IDiyas

For the Inventor, By the Inventor

Tokyo, Japan

Yasuo Shimoji

USPTO Granted Patents = 11

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 121(Granted Patents)


Location History:

  • Tokyo, JA (1977)
  • Hiromachi, JP (1987)
  • Tokyo, JP (1991 - 2005)

Company Filing History:

goldMedal11 out of 613 
 
Sankyo Company, Limited
 patents

Years Active: 1977-2005

Loading Chart...
11 patents (USPTO):Explore Patents
1. 6924279 - Crystalline 1-methylcarbapenem derivatives (2005-08-02),
2. 6090802 - 1- Methylcarbapenem derivatives (2000-07-18),
3. 5977097 - 1-methylcarbapenem derivatives (1999-11-02),
4. 5646171 - Angiotensin II antagonist 1-biphenylmethylimidazole compounds and their (1997-07-08),
5. 5616599 - Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their (1997-04-01),
6. 5459148 - Biphenyl derivatives and their use for the treatment of hypertension and (1995-10-17),
7. 5086057 - Method of treating cachexia and certain new compounds for use in this (1992-02-04),
8. 5055479 - Method of treating cachexia (1991-10-08),
9. 5002942 - 1,5-benzothiazepine derivatives, their preparation and their use in the (1991-03-26),
10. 4716162 - Fused 5 ring heterocyclic compounds, their preparation, and their (1987-12-29),
11. 4007189 - Pyrrolotriazolopyrimidine derivatives and process for the preparation (1977-02-08),

Title: The Innovations of Yasuo Shimoji: A Prominent Contributor to Antibiotic Development

Introduction

Yasuo Shimoji is a renowned inventor based in Tokyo, Japan, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 11 patents, Shimoji's work primarily focuses on the development of novel antibiotic compounds, showcasing his dedication to combating bacterial infections.

Latest Patents

Among his latest innovations are several patents for crystalline 1-methylcarbapenem derivatives. This groundbreaking invention provides crystalline forms of a 1-methylcarbapenem derivative, which exhibit remarkable antibiotic activity against various bacterial strains. These compounds are characterized by their sufficient stability for practical use, making them valuable in the pharmaceutical industry. Additionally, Shimoji has developed specific 1-methylcarbapenem derivatives, which are defined by complex chemical structures, highlighting his expertise in medicinal chemistry.

Career Highlights

Shimoji is currently affiliated with Sankyo Company, Limited, where he continues to advance his research in antibiotic development. His extensive work has significantly impacted the medical field, particularly in the development of new pharmaceutical therapies aimed at treating bacterial infections.

Collaborations

Collaboration is key in the scientific community, and Yasuo Shimoji has had the pleasure of working alongside esteemed colleagues, including Hiroyuki Koike and Hiroaki Yanagisawa. These collaborations have further enriched his research efforts, leading to innovative solutions in antibiotic therapies.

Conclusion

Yasuo Shimoji is a pivotal figure in the realm of pharmaceutical innovation, particularly in the development of antibiotics. His contributions, through a series of patents, reflect a commitment to enhancing treatment options for bacterial infections, ultimately benefiting the healthcare industry and patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…